Table 2 Laboratory studies at presentation with COVID-19, subdivided by the outcome of the hospital stay where available (n = 410)
From: COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease
All patients (n = 450) | By outcome of hospital stay, where available (n = 410) | p value for comparison | ||
|---|---|---|---|---|
Discharged (n = 237) | Died (n = 173) | |||
Lymphocyte count | 0.84 (0.58, 1.23) | 0.91 (0.67, 1.28) | 0.78 (0.535, 1.14) | 0.009 |
Neutrophil count | 5.72 (3.84, 8.61) | 5.32 (3.48, 7.82) | 6.6 (4.178, 9.750) | 0.001* |
Neutrophil: lymphocyte ratio | 221.5 (112.8, 333.2) | 217 (117, 323) | 239 (106.5, 343.5) | 0.676 |
CRP | 99 (46, 176.5) | 68 (31, 140) | 131 (74, 199) | < 0.001* |
CRP > 100, n (%) | 221 (49) | 83 (35) | 108 (62) | < 0.001* |
Procalcitonin | 0.26 (0.13, 0.73) | 0.20 (0.11, 0.44) | 0.37 (0.17, 1.35) | < 0.001* |
Troponin | 23 (9, 50) | 12 (6, 33) | 42 (20, 71.5) | < 0.001* |
Lactate | 1.3 (0.9, 1.8) | 1.2 (0.9, 1.6) | 1.5 (1.1, 2.25) | < 0.001* |
D-dimer | 1294 (616.5, 2429.8) | 1186 (535, 2340) | 1577 (814, 2548) | 0.014 |
Glucose | 6.6 (5.8, 8.3) | 6.5 (5.575, 8.0) | 6.9 (5.9, 8.625) | 0.017 |
Acute kidney injury, n (%) | 85 (19) | 24 (10) | 54 (31) | < 0.001* |